2018 AVBCC Summit Agenda

October 29-31, 2018 | New York Athletic Club, New York, NY

Monday, October 29

5:00 pm – 8:00 pm

Meet and Greet Networking Reception Honoring the Charitable Foundation for National Cancer Research Swim Across America

Co-Chairs

Burt Zweigenhaft, Managing Partner, Upstream Partners; Co-Founder, AVBCC
Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
William McGivney, Principal, McGivney Global Advisors
Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies

Co-Chair Segment Advisors

Washington Legislation and Public Policy
Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC
Cancer Centers of Excellence
Maurie Markman, MD, CMO, Cancer Treatment Centers of America
Robert Carlson, MD, CEO, National Comprehensive Cancer Network
Community-Based Cancer Care
Debra Pratt, MD, MPH, MBA, Texas Oncology
Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
Value-Based Performance and Standards
William McGivney, Partner, McGivney Global Advisors
Mark Fendrick, MD, University of Michigan Value-Based Insurance Design
Real-World Performance and Value-Based Care
Jennifer Hinkel, Partner, McGivney Global Advisors
Brent Clough, CEO, Trio Health
Practice Management
Jeffrey Scott, MD, President and CMO, Integra Connect
Brenton Fargnoli, MD, Product Marketing & Strategy, Flatiron Health
Personalized Medicine and Genomics
Louis Jacques, MD, ADVI Health LLC
Tom Civik, Chief Commercial Officer, Foundation Medicine
Oncology Supply Chain and Specialty Pharmacy
Darin Rubin, CEO, The Dedham Group
Kelly Ratliff, President, US BioServices Division, AmerisourceBergen
Patient-Centered Cancer Care
Lillie Shockney, RN, BS, MAS, Program Director and Co-Founder, Academy of Oncology Nurse & Patient Navigators
Brenda Nevidjon, RN, MSN, CEO, Oncology Nursing Society
Telemedicine and Cancer Care
Joel Stein, CEO, AdhereTech
Patient Voice and Advocacy
Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest
Amy Niles, VP, Patient Access Network Foundation

Tuesday, October 30

6:30 am – 8:00 am	Mini-Roundtables
6:30 am – 7:45 am	Breakfast – Ballroom Exhibit Hall
7:45 am – 8:00 am	Opening Remarks Burt Zweigenhaft, Co-Chair, AVBCC
8:00 am – 8:30 am	Keynote Scott Gottlieb, MD, FDA Commissioner
8:30 am – 9:00 am	Tomorrow’s Cancer Care: A Government Policy Perspective Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
9:00 am – 9:30 am	Tomorrow’s Cancer Care: An Insurance Payer’s Perspective Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Brian Loy, MD, Humana
9:30 am – 10:00 am	Tomorrow’s Cancer Care: A Community-Based Perspective Faculty: Barry Brooks, MD, US Oncology Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers Debra Pratt, MD, MPH, MBA, Texas Oncology
10:00 am – 10:30 am	Tomorrow’s Cancer Care: A Center of Excellence Perspective Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Maurie Markman, MD, CMO, Cancer Treatment Centers of America Robert Carlson, MD, CEO, National Comprehensive Cancer Network
10:30 am – 11:00 am	Tomorrow’s Cancer Care: An Employer’s Perspective Moderator: Jonathan Fassberg, CEO, Solebury Trout Faculty: John L. Donnelly, Head, Human Resources, JPMorgan Chase & Co Vice President, PNC Bank (TBD)
11:00 am – 11:30 am	Tomorrow’s Cancer Care: The Patient Voice and Advocate Perspective Moderator: Peter L. Saltonstall, President & CEO, National Organization for Rare Diseases Faculty: Dan Klein, President, Patient Access Network Patricia Goldsmith, CEO, CancerCare Clorinda Walley, CEO, Chronic Disease Fund
11:30 am – 12:00 pm	Tomorrow’s Cancer Care: A Pharma Perspective Moderator: Jonathan Fassberg, CEO, Solebury Trout Faculty: Mikael Dolstein, MD, President, World Research and Development, Pfizer Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline
12:00 pm – 12:45 pm	Lunch – Ballroom Exhibit Hall
1:45 pm – 2:15 pm	Keynote: Cancer Care into the Future Clifford Hudis, MD, FACP, CEO, American Society of Clinical Oncology
1:45 pm – 2:15 pm	Understanding Value Issues: Real-World Applications and Implications Moderator: William McGivney, Partner, McGivney Global Advisors Faculty: Richard Schilsky, MD, FACP, American Society of Clinical Oncology Steven Pearson, MD, MSc, President, Institute for Clinical and Economic Review Peter Bach, MD, Memorial Sloan Kettering Cancer Center
2:30 pm – 3:15 pm	BREAKOUT – Session 1: Pharmaceutical Industry Ecosystem Overview Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies Faculty: Michelle Drozd, Deputy VP, Policy and Research, Pharmaceutical Research and Manufacturers of America BREAKOUT – Session 2: Performance Optimization Strategies in Cancer Care Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Diana Verilli, VP, US Oncology McKesson BREAKOUT – Session 3: From K Street to Wall Street: A Look at Cancer Policy Influence on Markets Moderator: Ipsita Smolinski, CEO, Capitol Street Faculty: Lisa Gill, JPMorgan Chase & Co
3:15 pm – 4:00 pm	BREAKOUT – Session 4: Oncology Medical Home and Update on the CMMI Model Faculty: Anand Shah, MD, MPH, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services BREAKOUT – Session 5: Innovative Oncology Contracting Between Payers and Providers Moderator: Mark Fendrick, MD, University of Michigan Value-Based Insurance Design Faculty: Jim Kenney, VP, Harvard Pilgrim Health; President, Academy of Managed Care Pharmacy BREAKOUT – Session 6: Latest Trends on Off-Label Promotion: A Legal View
4:00 pm – 4:45 pm	BREAKOUT – Session 7: Cancer Treatment Innovation Pathways, Forums, and Clinical Tools Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health Anand Shah, MD, MPH, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services BREAKOUT – Session 8: Employers and Managing the Economic Reality of Cancer Spending Moderator: Randy Rosenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare BREAKOUT – Session 9: Biosimilars and Impact on Cancer Care Moderator: Bob Charles, MBA, CEO, The Generisys Company Faculty: Mark Vineis, Sandoz Robert Shelley, Pfizer
4:45 pm – 5:00 pm	Break
5:00 pm – 5:45 pm	Keynote – Cancer Drug Trend Report Moderator: Burt Zweigenhaft, Co-Chair, AVBCC Faculty: Doug Long, VP, Industry Relations, IQViA
5:45 pm – 7:45 pm	Evening Network Reception

Wednesday, October 31

7:00 am – 8:00 am	Mini-Roundtables
7:00 am – 8:00 am	Breakfast Presentation Oncology Drug Pipeline Overview, Next 3 Years Moderator: Burt Zweigenhaft, Co-Chair, AVBCC Faculty: Ray Trancredi, RPh, MBA, CSP, Divisional VP, Specialty Pharmacy Development & Brand Rx/Vaccine Purchasing, Walgreens Cheryl Allen, PharmD, Diplomat Specialty Pharmacy
8:00 am – 8:15 am	Opening Remarks Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 9:00 am	Keynote Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator Discussion with former Olympic cancer survivors Distinguished Researchers Panel Moderator: Neil Canavan, Author, The Cure Within Panelists: Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center Luis Diaz, MD, Memorial Sloan Kettering Cancer Center Axel Hoos, MD, President, Oncology, GlaxoSmithKline
9:00 am – 10:30 am	Cancer Care Perspectives from Capitol Hill and in Emerging Public Policy Moderator: Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC Faculty: Kavita Patel, Fellow, Brookings Institution Liz Fowler, VP, Global Health Policy, Johnson & Johnson
10:45 am – 11:15 am	Genomics and Personalized Medicine Moderator: Louis Jacques, MD, ADVI Health LLC Faculty: Selin Kurnaz, PhD, CEO, Massive Bio Vince Miller, MD, Foundation Medicine Edward Abramson, CEO, Personalized Medicine Coalition
11:15 am – 11:45 am	Economic Overview of Cancer Treatment Cost and Trends Moderator: Burt Zweigenhaft, Co-Chair, AVBCC Faculty: Bruce S. Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman
11:45 am – 12:30 pm	Future Trends and Observations in Cancer Care Ecosystem Moderator: Burt Zweigenhaft, Co-Chair, AVBCC Faculty: Dan Mendelson, President, Avalere Health
12:30 pm – 1:30 pm	Lunch Keynote Greg Simon, President, Biden Cancer Initiatives
1:45 pm – 2:30 pm	BREAKOUT – Session 10: Pharmacy Benefit Managers and Cancer Care Initiatives Moderator: Mike Ellis, CEO, Maxor National Pharmacy Services CVS OPTUM ExpressScripts BREAKOUT – Session 11: TeleHealth and Digital Medicine and Its Role in Cancer Care Faculty: Proteus BREAKOUT – Session 12: Wall Street and Investment in Cancer Care Ecosystems Moderator: David Vorhoff, VP, Premier Faculty: Richard Brown, SVP, PNC Bank
2:30 pm – 3:15 pm	BREAKOUT – Session 13: Strategies for Delivering on Pharmaceutical Value Moderator: Darin Rubin, CEO, The Dedham Group Faculty: Danielle Ziernicki, PharmD, Janssen Dina Smith, Bayer Matt Otten, Pharmacyclics BREAKOUT – Session 14: Big Data: “The New Oil” Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Brad Hirsch, MD, Senior Medical Director, Flatiron Health BREAKOUT – Session 15: Blockchain and Use Cases in Cancer Healthcare Moderator: John Bass, Hashed Health
3:15 pm – 4:00 pm	BREAKOUT – Session 16: Standardized Measurements and Process for Navigating Cancer Care Moderator: Lillie Shockney, RN, BS, MAS, Program Director and Co-Founder, Academy of Oncology Nurse & Patient Navigators Faculty: Tricia Strusowski, RN, MS Danelle Johnston, MSN, RN, ONN-CG, OCN BREAKOUT – Session 17: CAR-T Immuno-Oncology Session Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Novartis Bob Azelby, Chief Commercial Officer, Juno Therapeutics Alfred Slanetz, PhD, CEO, Geneius Biotechnology BREAKOUT – Session 18: Artificial Intelligence and Machine Learning Role in Cancer Care Moderator: Morrie Ruffin, CEO, Adjuvant Partners Faculty: T. May Pini, MD, Premier George Daneker, MD, Cancer Treatment Centers of America
4:00 pm – 4:45 pm	BREAKOUT – Session 19: Role of the Specialty Pharmacy in Cancer Care Moderator: Sheila Arquette, PharmD, Executive Director, National Association of Specialty Pharmacy Faculty: Ray Bailey, Director of Pharmacy, Florida Cancer Specialists Michael Agostino, CEO, Amber Specialty Pharmacy Matt Farber, Walgreens BREAKOUT – Session 20: Walking Barefoot in the Patient Role Moderator: Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest Faculty: Lillie Shockney, RN, BS, MAS, Program Director and Co-Founder, Academy of Oncology Nurse & Patient Navigators Brenda Nevidjon, RN, MSN, CEO, Oncology Nursing Society BREAKOUT – Session 21: Cancer Care Reimbursement Issues, Coding, and Trends Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies Faculty: Joel Brill, MD, CEO, Predictive Health
5:00 pm – 5:30 pm	Closing Remarks

*Agenda is subject to change.